Research & KnowledgeEvent: September 2, 2026
Deep Origin's computational platform contributed to a study published in Cell, identifying a lead compound from a library of molecular glues and matching results from Stanford and MD Anderson.
Published
Signal category
Research & Knowledge
Quote
“Deep Origin's computational platform just contributed to a study published in Cell — one of the top journals in the life sciences.”
— Tommy Sullivan 🇺🇦|Deep Origin team
Company
Deep Origin
Simulating life so we can build drugs faster. Building models that accurately predict what happens in humans.
- Industry
- Biotechnology Research
- Location
- South San Francisco, US
- Company size
- 103 employees
We help scientists solve disease, develop drugs, and extend healthspan by building tools that simplify R&D, simulate biology, and untangle the complexity of life. Streamline computational analysis today. Discover drugs tomorrow.
Founded 2022